Published by If you or someone in your household developed an infection or serious health complications after using DermaKleen, Dermasarra, KleenFoam, or Perigiene products, you may be entitled to legal compensation.
At Schmidt & Clark, we represent individuals harmed by contaminated consumer products. Our legal team can help assess your situation, gather evidence, and fight for the accountability you deserve. Contact Schmidt & Clark today for a free, no-obligation consultation.
Table Of Contents
What’s the Problem?
This issue stems from a voluntary nationwide recall of DermaRite Industries’ over-the-counter skincare products—DermaKleen antiseptic lotion soap, Dermasarra external analgesic, KleenFoam antimicrobial foam soap, and PeriGiene antiseptic cleanser—due to contamination with Burkholderia cepacia complex, a harmful bacteria.
While there have been no confirmed reports of illness to date, this pathogen can cause serious and potentially life-threatening infections, particularly in immunocompromised individuals, and may result in sepsis. Use of these products on broken skin or by those caring for vulnerable individuals could lead to bloodstream infections and severe medical complications.
Latest DermaKleen Lawsuit Updates
- August 8, 2025 – DermaRite Issues voluntary nationwide recall of DermaKleen, Dermasarra, KleenFoam, and PeriGiene products. Consumers and distributors are urged to destroy affected lots immediately [1.].
DermaKleen Lawsuit Statistics
- Products involved: DermaKleen lotion soap, Dermasarra external analgesic, KleenFoam antimicrobial foam soap, PeriGiene antiseptic cleanser.
- Recall scope: Affected lots distributed nationwide to retailers, pharmacies, and health facilities—including potential use among vulnerable populations.
- Reported harms: No confirmed illnesses or injuries reported through date, though the contamination hazard remains serious.
- Legal activity: No lawsuits or class actions filed yet; outreach and case screening are beginning.
FDA Recall Details
- Recall initiated due to identification of Burkholderia cepacia complex contamination—microbe known to cause severe infections in immunocompromised individuals.
- While healthy users with minor skin lesions may suffer only localized infection, high-risk individuals, including those with weakened immune systems, are at risk of bloodstream infection and life-threatening sepsis.
- DermaRite has not recorded any adverse event reports related to this contamination, but cautioned that risk remains high.
- Consumers and distributors were directed to destroy remaining product inventory and contact DermaRite for assistance.
Potential Injuries & Side Effects
Contamination with Burkholderia cepacia in OTC skincare can result in serious harm, including:
- Local skin infections: Redness, swelling, or inflammation—especially on broken or damaged skin.
- Systemic infections: Bloodstream infection (septicemia), pneumonia, or sepsis, particularly in immunocompromised patients.
- Sepsis and organ failure: Rapid infection spread leading to hospital admission, intensive treatment, or life-threatening complications.
Do You Qualify for a DermaKleen Lawsuit?
- You or a family member used DermaKleen, Dermasarra, KleenFoam, or PeriGiene products from affected lots in 2025.
- You experienced a medical infection or were medically evaluated for infection after product use.
- A healthcare provider attributed your symptoms to possible bacterial exposure from these products.
- You have documentation: product packaging, purchase receipt, medical records, or lab tests.
- No legal claim has yet been filed, and you seek assistance with next steps.
Evidence You’ll Need
- Product evidence: Any unused containers or packaging; order receipts or lot numbers matching the recall list.
- Medical documentation: Doctor or hospital records, lab results confirming infection or antimicrobial testing.
- Exposure history: Timeline showing product use and onset of symptoms.
- Recall verification: Materials or media confirming recall or contamination associated with product lot.
Damages You Can Recover
Claims stemming from contaminated skincare products may include:
- Medical bills—clinic or hospital visits, diagnostics, treatment for infection or sepsis.
- Out-of-pocket expenses—medication, transport, caregiving costs related to illness.
- Pain and suffering—physical discomfort and emotional trauma from infection or caretaking.
- Potential punitive damages—if evidence shows reckless contamination or failure to warn.
Recall Overview
- Recall announcement: August 8, 2025 by DermaRite Industries.
- Affected products: DermaKleen, Dermasarra, KleenFoam, and PeriGiene OTC products.
- Hazard: Contamination with Burkholderia cepacia complex.
- Geography: Nationwide U.S. distribution, including retail and healthcare settings.
- Consumer response: Dispose or destroy affected products immediately; seek medical advice if symptoms arise.
Statute of Limitations
Product liability and personal injury claims generally must be filed within two to three years of injury or discovery, subject to state law. With recall announced in August 2025, we urge any affected individuals to consult legal counsel promptly to preserve their rights. Special deadlines may apply in cases involving serious infection or death—timely action is critical.
Frequently Asked Questions
- How do I file a claim? Contact a personal injury or product liability attorney. We can guide you through evaluating your case and filing paperwork.
- Who qualifies? Individuals who used recalled DermaRite products and developed infection or medical symptoms.
- What compensation is available? Medical costs, out-of-pocket expenses, emotional trauma, and possibly punitive damages.
- Is it a class action? Not yet; however, multiple similar cases may eventually consolidate.
- What should I keep? Product evidence, medical records, purchase receipts, and recall documentation.
- If infection not confirmed? Seek medical evaluation—early documentation supports claims and health outcome tracking.
Start Your Free Case Review Now
References
- https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dermarite-industries-issues-voluntary-nationwide-recall-dermakleen-dermasarra-kleenfoam-and